Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0O4JH
|
|||
Former ID |
DNC000144
|
|||
Drug Name |
ACEA-1328
|
|||
Indication | Cancer related pain [ICD-11: MG30; ICD-10: R52.1, R52.2] | Terminated | [1] | |
Therapeutic Class |
Analgesics
|
|||
Structure |
Download2D MOL |
|||
Formula |
C10H9N3O4
|
|||
Canonical SMILES |
CC1=CC2=C(C(=C1C)[N+](=O)[O-])NC(=O)C(=O)N2
|
|||
InChI |
1S/C10H9N3O4/c1-4-3-6-7(8(5(4)2)13(16)17)12-10(15)9(14)11-6/h3H,1-2H3,(H,11,14)(H,12,15)
|
|||
InChIKey |
CYJRVSOLVYLORV-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | N-methyl-D-aspartate receptor (NMDAR) | Target Info | Antagonist | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800007690) | |||
REF 2 | Emerging analgesics in cancer pain management. Expert Opin Emerg Drugs. 2005 Feb;10(1):151-71. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.